Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Ottawa

$27,000.00

Improving Care Pathways for Glioblastoma Through Decision Support Tools

FY 2025-26

Summary
Glioblastoma (GBM) is the most fatal form of brain cancer, characterized by a high symptom burden and poor prognosis under the current standard of care. Patients with GBM and their care partners face high stakes decisions about treatment, often without sufficient understanding of the disease trajectory or options such as repeat surgery when the tumour recurs. The complexity and emotional weight of this decision underscores the importance of shared decision-making, a collaborative process that allows patients, care partners, and providers to work together to make decisions. However, shared decision-making in GBM care is often hindered by information gaps, cognitive deficits, and emotional distress. To address these challenges, I will co-create a technology-enabled patient decision aid that adapts to varying cognitive abilities, incorporates patient and care partner input throughout development, and explores the use of artificial intelligence to enhance personalization and cognitive optimization. This research will progress through two primary objectives: 1) develop and pilot the aid using user-centered principles and the Ottawa Decision Support Framework, with content and design refined through cycles of expert steering committee review and usability testing with patients and care partners with lived experience of GBM; 2) design a randomized controlled trial protocol informed by pilot findings and aligned with SPIRIT and CONSORT 2025 guidelines. This work will advance patient-centered GBM care by supporting patient autonomy and true informed consent, reducing decisional conflict and regret, respecting patient wishes to be active participants in their care, and alleviating the emotional burden placed on patients and care partners in making these difficult decisions.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573259
Name
Dudding Jessie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving Care Pathways for Glioblastoma Through Decision Support Tools
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Artificial Intelligence; Co-Design; Cognitive Ability; Glioblastoma; Patient Decision Aid; Patient-Centred; Recurrence; Repeat Surgery; Shared Decision-Making
Abstract
Glioblastoma (GBM) is the most fatal form of brain cancer, characterized by a high symptom burden and poor prognosis under the current standard of care. Patients with GBM and their care partners face high stakes decisions about treatment, often without sufficient understanding of the disease trajectory or options such as repeat surgery when the tumour recurs. The complexity and emotional weight of this decision underscores the importance of shared decision-making, a collaborative process that allows patients, care partners, and providers to work together to make decisions. However, shared decision-making in GBM care is often hindered by information gaps, cognitive deficits, and emotional distress. To address these challenges, I will co-create a technology-enabled patient decision aid that adapts to varying cognitive abilities, incorporates patient and care partner input throughout development, and explores the use of artificial intelligence to enhance personalization and cognitive optimization. This research will progress through two primary objectives: 1) develop and pilot the aid using user-centered principles and the Ottawa Decision Support Framework, with content and design refined through cycles of expert steering committee review and usability testing with patients and care partners with lived experience of GBM; 2) design a randomized controlled trial protocol informed by pilot findings and aligned with SPIRIT and CONSORT 2025 guidelines. This work will advance patient-centered GBM care by supporting patient autonomy and true informed consent, reducing decisional conflict and regret, respecting patient wishes to be active participants in their care, and alleviating the emotional burden placed on patients and care partners in making these difficult decisions.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dudding, Jessie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~